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PROBABILISTIC PROJECTIONS OF HIV PREVALENCE USING
BAYESIAN MELDING1
By Leontine Alkema, Adrian E. Raftery and Samuel J. Clark
University of Washington
The Joint United Nations Programme on HIV/AIDS (UNAIDS)
has developed the Estimation and Projection Package (EPP) for mak-
ing national estimates and short-term projections of HIV prevalence
based on observed prevalence trends at antenatal clinics. Assessing
the uncertainty about its estimates and projections is important for
informed policy decision making, and we propose the use of Bayesian
melding for this purpose. Prevalence data and other information
about the EPP model’s input parameters are used to derive a proba-
bilistic HIV prevalence projection, namely a probability distribution
over a set of future prevalence trajectories. We relate antenatal clinic
prevalence to population prevalence and account for variability be-
tween clinics using a random effects model. Predictive intervals for
clinic prevalence are derived for checking the model. We discuss pre-
dictions given by the EPP model and the results of the Bayesian
melding procedure for Uganda, where prevalence peaked at around
28% in 1990; the 95% prediction interval for 2010 ranges from 2% to
7%.
1. Introduction. In this article we propose a way to obtain probabilistic
projections of HIV prevalence for generalized epidemics in countries with
little detailed knowledge of HIV prevalence. A generalized HIV epidemic af-
fects the general population beyond high risk sub-populations. To qualify as
generalized under WHO and UNAIDS definitions, an epidemic must affect
one percent or more of pregnant women [Ghys et al. (2004)] and, by this def-
inition, many countries in sub-Saharan Africa have generalized HIV/AIDS
epidemics. In countries with high HIV prevalence the effects of the epidemic
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on the population are significant, and prevalence predictions are necessary
to understand and plan for these effects in the future.
UNAIDS has to produce current estimates and short-term projections of
HIV prevalence for all countries with generalized HIV epidemics. It devel-
oped the Estimation and Projection Package (EPP) for this purpose. EPP
is designed to reproduce the overall dynamics of a generalized HIV epidemic
in a parsimonious way. To achieve this, the EPP model must be general,
robust and simple; simple because many countries with generalized HIV
epidemics have few data to describe those epidemics. For most countries
in sub-Saharan Africa, the main source of information on HIV prevalence
is the prevalence of HIV among women who attend antenatal clinics. As
a result, the EPP model is designed to produce past and future trends in
HIV prevalence that are consistent with measured trends in antenatal clinic
prevalence. For a small number of countries, more data of higher quality
are available. It is conceivable that for those countries one could design a
model that would be better able to capture the complex dynamics revealed
by the data. However, this would violate the UNAIDS requirement that a
single consistent method be used to produce estimates and projections of
HIV prevalence for all affected countries, and could confuse comparison of
the estimates between countries, and across time for the same country.
The EPP 2005 software and supporting documentation can be down-
loaded from www.unaids.org. EPP is used by UNAIDS, the World Health
Organization and a variety of national and other agencies to produce HIV
prevalence estimates. EPP is often used in combination with Spectrum,
an extended sex- and age-differentiated population model [Stover (2004),
Stover et al. (2006)]. Spectrum uses the prevalence trends generated by EPP
to produce annual sex- and age-specific HIV incidence, deaths and other
quantities of interest. EPP and Spectrum together have been used to an-
alyze the global impact of HIV/AIDS prevention and treatment programs,
and the World Health Organization has proposed using their combined out-
put to estimate the number of people in need of antiretroviral treatment.
Uncertainty is inherent in forecasts of future trends in HIV prevalence,
and assessing it is crucial for policy decision making. In 2003, UNAIDS
included information on uncertainty in its estimates and projections by cal-
culating and presenting plausibility bounds [Grassly et al. (2004)]. These
bounds were derived by combining the results of a bootstrap method with
expert opinion regarding the range of possible epidemic curves. As noted
by Morgan et al. [(2006), page iii77]: “plausibility bounds do not represent
and should not be interpreted as formal statistical confidence intervals.” A
Bayesian framework solves this problem by providing a way of including
expert opinion while still giving formal statistical confidence intervals.
We propose Bayesian melding to obtain probabilistic projections of HIV
prevalence. Bayesian melding was first developed to estimate the rate of in-
crease of whale populations [Raftery et al. (1995), Poole and Raftery (2000)],
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and was successfully applied to policy-making in that context. Bayesian
melding fully accounts for information describing uncertainty in both the
inputs and outputs of a deterministic model. In this paper we discuss the
application of the Bayesian melding procedure to the EPP model. In Section
2 we describe the EPP model, in Section 3 we explain the Bayesian melding
procedure and a random effects model for HIV prevalence, in Section 4 we
present results for urban HIV prevalence in Uganda, and in Section 5 we
discuss possible improvements to the methodology.
2. The Estimation and Projection Package. The Estimation and Projec-
tion Package (EPP) was developed by UNAIDS to satisfy two major con-
straints. First it has to be able to capture the main dynamics of an HIV epi-
demic in any country, often without detailed knowledge of the transmission
patterns in that country, and second it has to be simple enough to be used
by national planning officials in a wide variety of developing countries. The
UNAIDS Reference Group on Estimates, Modeling and Projections (2002)
recognized that there are many complex models that incorporate patterns
of risk behavior and mixing, and provide useful tools for understanding the
spread and control of HIV. Many of these models are unsuitable for the task
at hand, however, because they require a large number of biological and be-
havioral parameter values that are not available from all the countries that
require estimates and projections of HIV prevalence.
UNAIDS has developed a simple epidemiological Susceptible-Infected model
that satisfies these two constraints. The population at time t is divided into
three groups, a not-at-risk group X(t), an at-risk group Z(t) and an in-
fected group Y (t). The model assumes a constant non-AIDS mortality rate
µ and fertility rate b and does not represent migration or age structure.
Time-evolving prevalence (the fraction of the population infected) is mod-
eled with four parameters that need to be estimated, r, f0, t0 and φ. The
parameter r is the rate of infection, f0 is the fraction of the population in
the at-risk category at the start of the epidemic, t0 is the start time of the
epidemic and φ is the behavioral response.
The influence of each of these parameters on the shape of the epidemic is
shown in Figure 1. Note the standard overall shape of the epidemic in all of
the plots. The fraction of the HIV negative population infected each year,
or incidence, increases to a maximum and declines thereafter. As long as the
number of new HIV infections is greater than the number of AIDS deaths,
the prevalence rate increases. An epidemic peaks when the incidence and
mortality rates are about equal. After the peak the prevalence rate comes
down because the number of AIDS deaths continues to increase as a result of
the lag between becoming infected and dying of AIDS. An epidemic stabilizes
when the number of new HIV infections equals the number of AIDS deaths.
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Fig. 1. The influence of r, f0, t0 or φ on the shape of the epidemic curve while holding
other parameters fixed at the values r= 2, f0 = 0.4, t0 = 1980, φ= 0.
The greater the rate of infection r, the faster prevalence increases at the
beginning of the epidemic, as can be seen from Figure 1(a). If a fraction f of
the population is at risk of HIV infection, every infected person infects r · f
people each year (r · f is called the force of infection). The fraction of the
population in the at-risk category at the start of the epidemic f0 influences
when and at what prevalence the epidemic peaks. If a higher proportion of
the population is initially at risk, the epidemic will peak sooner and at a
higher level, as can be seen in Figure 1(b). The epidemic is shown for two
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different start years in Figure 1(c). Changing the start year, t0, does not
change the shape of the epidemic, only its timing.
The behavioral response, φ, influences the level at which the epidemic
levels off after the peak, as shown by Figure 1(d). The parameter φ is pos-
itively related to steady state prevalence. Negative values of φ correspond
to a situation in which new members of the population change their behav-
ior when they see others dying of AIDS, so that fewer of them enter the
at-risk group. Positive values of φ correspond to the opposite situation in
which a larger fraction of new members enter the at-risk group. This could
be due to pockets of the population that were previously isolated, perhaps
by geography or culture, being exposed to infection.
The rates at which the sizes of the groups change—through recruitment,
behavior and infection—are described by three differential equations:

dX(t)
dt
=
(
1− f
(
X(t)
N(t)
, f0, φ
))
E(t)− µX(t),
dZ(t)
dt
= f
(
X(t)
N(t)
, f0, φ
)
E(t)−
(
µ+ r
Y (t)
N(t)
+ λ(t)
)
Z(t),
dY (t)
dt
=
(
r
Y (t)
N(t)
+ λ(t)
)
Z(t)−
∫ t
0
(
r
Y (τ)
N(τ)
+ λ(τ)
)
Z(τ)g(t− τ)dτ,
where N(t) is the total population, N(t) =X(t) +Z(t)+ Y (t), and µ is the
nonHIV death rate. The function g(τ) specifies the HIV death rate τ years
after infection. Survival after infection is assumed to have a Weibull(2.4,
10.5) distribution, so that the median survival time is 9 years. The start
year of the epidemic is defined as the first year in which people are infected;
the time at which a fraction λ0 of the at-risk group Z moves to the infected
group Y . Similar epidemics can be generated with either a larger, earlier
pulse or a smaller, later pulse. We set λ0 = 0.001 so that 0.1% of the at-
risk population gets infected in the start year. The initial pulse is modeled
such that λ(t) = λ0 · δ(t− t0), where δ(t) is the Dirac Delta function, and so∫
∞
−∞
λ(t)Z(t)dt= λ0Z(t0).
The population being modeled is aged 15+. New members of the popu-
lation are the ones who survive to age 15. When entering the population,
they are assigned to either the not-at-risk group X(t) or the at-risk group
Z(t). The total number of new members at time t, E(t), depends on the
population size 15 years ago, the birth rate and the survival rate from birth
to age 15. The birth rate is applied to both the uninfected and infected
groups, taking into account the HIV-related fertility reduction experienced
by the infected group and the transmission of HIV from mother to child.
A fraction of the new 15-year-old members enter the at-risk group Z(t) at
time t. This fraction is given by f(X(t)N(t) , f0, φ) (defined later in Section 3.2),
and depends on the fraction of the population in the not-at-risk group, the
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fraction initially at risk, and the behavioral response φ. The remainder of
the new 15-year-olds enter the not-at-risk group X(t).
3. Bayesian melding for the EPP model.
3.1. Bayesian melding. The EPP model transforms the input θ, consist-
ing of the four input parameters (r, f0, t0, φ), into the output ρ, consisting
of a series of HIV prevalence rates for the population during a given period.
We denote the EPP model by M , so that ρ =M(θ). The Bayesian meld-
ing procedure [Poole and Raftery (2000)] combines information on inputs
and outputs. In the case of the EPP model, these consist of prior knowl-
edge about the inputs, and prior knowledge and data informative about the
outputs.
First consider the melding of all information about outputs. Let W de-
note the data that are informative about prevalence rates. The prevalence
data yield a likelihood, p(W |ρ), for the model output ρ. Expert knowledge
provides a prior distribution p(θ) for the inputs. This prior density induces
a prior density on the outputs ρ, because ρ is a transformation of θ; we
denote this induced prior on the outputs by p∗(ρ).
Expert knowledge about prevalence is specified by a prior distribution
of prevalence in certain years. Here this prior is taken to be independent
between years, and uniform between upper and lower bounds for each year.
For example, restricting prevalence in 1980 to be smaller than 10% is repre-
sented by the prior distribution ρ1980 ∼U(0,10). This results in a direct (as
opposed to induced) prior distribution p(ρ) on the outputs, given by
p(ρ)∝
∏
t∈Γ
IVt(ρt),
where Γ is the set of years for which there is prior knowledge, Vt is the
interval given by the lower and upper bounds on prevalence in year t, and
IA(x) is the indicator function for a set A, equal to 1 if x ∈ A and to 0 if
not.
As proposed by Poole and Raftery (2000), the two prior distributions on
the output, namely, the induced prior p∗(ρ) and the direct prior p(ρ), are
combined using logarithmic pooling:
p˜(ρ)∝ p∗(ρ)αp(ρ)1−α,(1)
where p˜(ρ) is the pooled prior and α is the pooling weight. Because the di-
rect prior distributions are uniform on intervals, we let α ↑ 1; note that the
resulting limiting pooled prior is not the same as that obtained by setting
α= 1 in (1). The resulting pooled prior on outputs incorporates the bound-
aries on outputs as given by expert opinion on outputs, while remaining
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maximally faithful to the prior induced by the inputs. The pooled prior of
the output is then
p˜(ρ)∝ p∗(ρ)
∏
t∈Γ
IVt(ρt).
The posterior distribution of the output is then given by
p(ρ|W )∝ p˜(ρ)p(W |ρ).(2)
By similar reasoning, the posterior distribution of the inputs is given by
p(θ|W )∝ p˜(θ)p(W |M(θ)),(3)
where p˜(θ) is the pooled prior on the inputs and p(W |M(θ)) is the likelihood
of the inputs. The pooled prior on the inputs, p˜(θ), is given by the limit of
equation (16) of Poole and Raftery (2000) as α ↑ 1. In the present case,
this simplifies to the direct prior density restricted to the region of input
parameter space where the constraints on outputs are satisfied, and rescaled
accordingly.
It is not possible to write the posterior distributions in (2) and (3) analyt-
ically because the model is not invertible. We approximate it using Monte
Carlo methods, by drawing a random sample from it using the Sampling
Importance Resampling algorithm [Rubin (1987, 1988)]:
1. Sample {θ(1), . . . ,θ(n)} from the input prior p(θ) on θ = (r, f0, t0, φ).
2. For each θ(i), determine the corresponding series of prevalence rates,
ρ(i) =M(θ(i)), by running the EPP model. This gives a sample from
the induced prior p∗(ρ) on the outputs.
3. Form the sampling importance weights for each ρ(i) [and thus for each
θ(i)] as the product of the likelihood and the direct prior of ρ(i):
wi = p(W |ρ
(i))
∏
t∈Γ
IVt(ρ
(i)
t ).
4. Sample from the discrete distribution of {θ(1), . . . ,θ(n)} with probabili-
ties proportional to wi to approximate the posterior distribution for the
inputs, and do the same for the outputs.
3.2. Priors on input parameters. We specify a joint prior distribution for
the four input parameters θ = (r, f0, t0, φ). Separate sources of information
are used to specify each of these priors, and so we specify these four param-
eters to be independent a priori. We assume that the rate of infection r can
take any value between 0 and 15 with equal probability, r ∼U [0,15], mean-
ing that the average number of people an infected person infects per year
can range from zero to 15 times the fraction at risk. The start year of the
epidemic t0 has a uniform discrete distribution on {1970,1981, . . . ,1990}.
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The fraction initially at risk f0 can be any value between zero and one,
f0 ∼ U [0,1]. We assume a uniform prior on [0,1] for the fraction entering
the at-risk population f(X(t)N(t) , f0, φ). These two priors together define a prior
for the behavioral response φ. In the model, the fraction entering the at-risk
group Z(t) is given by
f
(
X(t)
N(t)
, f0, φ
)
=
exp((φχ(t)))
exp((φχ(t)))− 1 + 1/f0
,(4)
where χ(t) is the difference between the fraction in the not-at-risk group at
time t, namely, X(t)/N(t), and the fraction (1− f0) that was not at risk at
the beginning of the epidemic. Thus,
χ(t) =
X(t)
N(t)
− (1− f0).(5)
Using (4), φ can be written in terms of the fraction entering the at-risk
group and the fraction initially at risk. With uniform priors on both these
fractions, the behavioral response parameter has a logistic distribution with
mean 1χ log(
1
f0
− 1) and variance pi
2
3χ2 , and with an initial estimate f0 = 0.5,
it is centered around zero. The smaller the prior estimate of χ is, the more
spread out the prior distribution for the behavioral response will be. We
set χ = 0.1 meaning that a priori we expect an average difference of 10%
between the current and initial fractions not at risk.
3.3. Likelihood for population prevalence. In many of the countries with
generalized HIV/AIDS epidemics, the data available for calibrating the EPP
model consist of estimated prevalences among pregnant women at antenatal
clinics. We will consider calibration of the EPP model in a country, or a
part of a country, that is considered to be relatively homogeneous in terms
of the pattern of the epidemic. UNAIDS often considers the urban areas of
a country to form one such homogeneous part, and the rural areas to form
another part. Here we assume that the prevalence among the attendees at
an antenatal clinic gives an unbiased estimate of population prevalence (but
see discussion in Section 5).
We now derive an output likelihood for the data, namely, the antenatal
clinic prevalences, given the model outputs, namely, the population preva-
lences for each year during the observation period, ρ = (ρ1, . . . , ρT ), where
ρt is the overall population prevalence in year t. The data consist of the
number of infected women, Yst, and the number of women tested, Nst, for
clinic s in year t, for the S clinics s= 1, . . . , S. Data are available for clinic s
for the years t= t(s,1), . . . , t(s,Ts), where Ts is the number of years in which
data were collected at clinic s.
We denote by γst the prevalence at clinic s in year t. We assume that
Yst ∼ Binomial(Nst, γst), and that the Yst are conditionally independent of
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each other given the γst. Antenatal clinic data often include repeated mea-
surements at the same clinic. To account for this repeated measurement
structure, we approximate the likelihood by modeling Yst on the probit
scale and using a hierarchical normal linear model. We let Wst =Φ
−1(xst),
where Φ(·) is the standard normal cumulative distribution function, and
xst = (Yst +
1
2)/(Nst +1). The constants
1
2 and 1 in the definition of xst are
introduced for computational reasons, to avoid problems with zeros. They
also have an approximate Bayesian motivation because xst would be the
posterior mean of γst with a noninformative Jeffreys Beta(
1
2 ,
1
2 ) prior distri-
bution, in the absence of any other information.
Our model is then
Wst = Φ
−1(ρt) + bs + εst,(6)
bs
iid
∼ N(0, σ2),(7)
εst
ind
∼ N(0, vst),(8)
with
vst = 2pi exp{Φ
−1(γst)
2}γst(1− γst)/Nst.(9)
In (6), bs is the clinic random effect for clinic s, assumed to be constant over
time. The error term εst approximates the binomial variation. Equation (9)
is an approximation derived from the binomial distribution of Yst using the
delta method.
Bayesian estimation of the model (6)–(8) requires a prior only for σ2, and
we use a standard Inverse Gamma (β1, β2) prior. To assess values of β1 and
β2, we considered the results of fitting the model to urban antenatal clinic
data from nine countries in sub-Sarahan Africa, and chose values of β1 and
β2 that made this prior distribution spread out enough to amply cover the
results of the model fits, namely, β1 = 0.58, β2 = 93.
We now use the model (6)–(8) to derive the likelihood of the data W =
(W s : s= 1, . . . , S), whereW s = (Wst : t= t(s,1), . . . , t(s,Ts)), given the pop-
ulation prevalences ρ = (ρ1, . . . , ρT ). This likelihood follows by integrating
out the clinic random effects, b= (b1, . . . , bS), and the random effects vari-
ance, σ2, as follows:
p(W |ρ) =
∫ ∫
p(W |ρ,b)p(b|σ2)dbp(σ2)dσ2
=
∫ ∫ { S∏
s=1
p(Ws|ρ, bs)p(bs|σ
2)
}
dbp(σ2)dσ2(10)
=
∫ { S∏
s=1
As(σ
2)
}
p(σ2)dσ2,
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where As(σ
2) =
∫ ∏S
s=1 p(Ws|ρ, bs)p(bs|σ
2)dbs.
The quantity As(σ
2) can be evaluated analytically as follows. Let dst =
Wst−Φ
−1(ρt) and ds = (ds,t(s,1), . . . , ds,t(s,Ts)). Then ds = bs1Ts + εs, where
1Ts is a Ts-vector of ones and εs = (εs,t(s,1), . . . , εs,t(s,Ts)). Thus, ds ∼
MVNTs(0,Σs), whereΣs = σ
2JTs+V s, with JTs defined as a Ts×Ts matrix
all of whose elements are one, and V s = diag(vst : t= t(s,1), . . . , t(s,Ts)). It
follows that As(σ
2) is equal to the MVNTs(0,Σs) density evaluated at ds.
The error variance vst is approximated as in (9) with γst = xst.
We have now reduced the integral (10) to a one-dimensional integral.
This has no analytic solution and we evaluate it using numerical quadrature,
specifically the globally adaptive interval subdivision method [Piessens et al.
(1983)], as implemented in the R function integrate.
3.4. Assessing model fit: Predictive distribution for clinical prevalence.
We assess the fit of the overall prediction procedure, including the EPP
model itself, the Bayesian melding estimation method and the approxima-
tions we have used in deriving the likelihood, using out-of-sample predictive
distributions. We are therefore interested in the predictive distribution of
observed prevalence at clinic s at a future time u > T . Clinic-specific pre-
diction intervals can be used to evaluate the predictive quality of the EPP
model by forecasting prevalence using data before a given point in time and
comparing the predictive distributions with observed clinic prevalence for
the years after that point, viewed as a test sample.
A sample from the posterior distribution of population prevalence for
observed and future years, p(ρ|W ), is given by the Bayesian melding output,
ρ(1), . . . ,ρ(J), where ρ now includes future prevalences up to year u, so
that ρ= (ρ1, . . . , ρT , ρT+1, . . . , ρu). The predictive distribution of the future
transformed observed prevalence at clinic s and time u is
p(Wsu|W ) =
∫ ∫
p(Wsu|bs,ρ)p(bs|ρ,W )dbsp(ρ|W )dρ.
A Monte Carlo approximation to this is
1
J
J∑
j=1
p(Wsu|b
(j)
s ,ρ
(j)
u ),
where b
(j)
s is one value sampled from p(bs|ρ
(j),W ). This density is propor-
tional to
p(bs|ρ
(j),W ) = p(bs|d
(j)
s )(11)
∝ p(d(j)s |bs)p(bs)(12)
∝ exp
(
−
1
2
Ts∑
t=1
(d
(j)
st − bs)
2
vst
)(
1
2
b2s +
1
β2
)
−β1−1/2
,(13)
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because d(j)s |bs ∼MVNTs(bs1Ts ,V s) and the marginal prior distribution of
bs is proportional to (
1
2b
2
s +
1
β2
)−β1−1/2.
We sample from p(bs|d
(j)
s ) using rejection sampling. Then the predictive
distribution of the transformed observed prevalence is
Wsu|b
(j)
s , ρ
(j)
u ∼N(ω
(j)
u + b
(j)
s , v
(j)
su ),
where ω
(j)
u = Φ−1(ρ
(j)
u ), and v
(j)
su is given by (9) with γsu = Φ(ω
(j)
u + b
(j)
s ).
Transforming the prevalence back to its original scale gives a sample from
the posterior predictive distribution of the future observed prevalence.
4. Results. Data on prevalence at urban and rural antenatal clinics are
available from the Epidemiological Fact Sheets on HIV/AIDS and Sexually
Transmitted Infections 2006 at
http://www.who.int/globalatlas/predefinedReports/EFS2006/index.asp. As
an example, we will discuss urban prevalence in Uganda, from where an-
tenatal clinic prevalence data are available through 2002. Prevalence was
observed at five clinics in Kampala and most of the observations were at
two missionary hospitals. Prevalence has been falling since the early 1990s,
as can be seen from Figure 2, which plots observed prevalence against time.
We ran the Bayesian melding procedure as described in the previous
section for the five urban clinics in Uganda. We sampled 200,000 combi-
nations of the input parameters from their prior distribution as described
in Section 3.2. We restricted prevalence in 1980 to be smaller than 10%,
ρ1980 ∼ U(0,10). After calculating the weights for each of those inputs, we
resampled 3,000 trajectories of which 373 were unique. The trajectory with
the largest likelihood was resampled 120 times. Figure 2 shows the poste-
rior sample of epidemic curves. The decrease in prevalence is projected to
continue until around 2015 when it levels off between 1% and 6%, with a
posterior median of about 3%. Figure 3 shows histograms of the samples of
posterior predictive prevalence for 2005 and 2010. Although there is consid-
erable uncertainty about the prevalence in any given future year, the results
clearly predict a continuing overall decline in prevalence.
Figure 4 displays the prior density and the histogram of a sample from
the posterior distribution of each of the four input parameters. The posterior
mean of the rate of infection r is 4.6 (95% confidence interval [1.8, 12.7]),
meaning that on average each year an infected person infects a number of
people equal to between 2 and 13 times the at-risk fraction of the population.
The posterior median of the start year t0 is 1979 (95% confidence interval
[1972, 1983]). The fraction initially at risk f0 is centered around 0.32 (95%
confidence interval [0.26, 0.39]). The behavioral response φ is negative with
a mean of −5.6 (95% confidence interval [−9.3, −3.0]). This means that as
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Fig. 2. Posterior distribution of urban HIV prevalence in Uganda over time. Each dot
is an observation, and dots with the same symbol correspond to repeated observations at
the same clinic. Each grey line is a unique trajectory in the posterior sample of epidemic
curves. The dashed lines are the 2.5% and 97.5% quantiles, and the solid black line is the
median of the posterior sample.
Fig. 3. Sample from the posterior predictive distribution of urban HIV prevalence in
Uganda in 2005 and 2010.
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Fig. 4. Posterior samples (histograms) and prior densities (solid lines or curve) of input
parameters for urban prevalence in Uganda: (a) r; (b) f0; (c) t0; (d) φ.
the number of AIDS deaths grows, the proportion of 15 year olds drawn into
the at-risk group declines.
Even though they are independent a priori, the four parameters of the
EPP model are correlated a posteriori. Often the posterior relationship be-
tween the parameters is nonlinear. For example, in Figure 5 the rate of
infection r is plotted against the start year of the epidemic t0. This shows
the classic “banana shape” often seen in posterior distributions of the pa-
rameters of deterministic simulation models of this kind; see Raftery et al.
(1995) for other examples. In this case the banana shape of the posterior
arises because the data contain substantial information about the product
of the rate of increase r and the time since the start of the epidemic (t− t0)
but less information on either r or (t− t0) individually, as can be seen from
Figure 4. As a result, the product r(t− t0) is fairly well identified, leading
roughly to a reflected hyperbola in the plot of the joint posterior distribution
of r and t0.
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To assess the predictive performance of our method, we ran Bayesian
melding using data from different truncated time periods, and compared the
predicted to the observed prevalences for the remaining years, viewed as a
test dataset. Figure 6 displays the prediction intervals for urban prevalence
based on data through 1994, 1998 and 2002. Each grey line is a unique
trajectory from the posterior sample of epidemic curves, the dotted lines are
the 2.5% and 97.5% quantiles, and the solid black line is the median of the
posterior sample for each year.
Figure 6(a) shows results based on observed prevalence through 1994 (the
vertical line). At that time it was predicted that prevalence would decline,
but there was a great deal of uncertainty about future prevalence. Based
on the data through 1994 only, the 95% prediction interval for 2010 was
[0%, 23%] with a median prediction of 1%. The subsequent clinic observa-
tions for 1995–2002 lay well within the posterior intervals for future overall
prevalence. (In interpreting this result, it should be borne in mind that these
bounds give predictive intervals for national urban prevalence and not for
individual clinic observations.) Based on data through 1998, the posterior
predictive distribution of prevalence in 2010 was much more concentrated,
with a 95% interval [0%, 7%] instead of [0%, 23%], although the poste-
Fig. 5. Sample from the joint posterior distribution of the rate of infection, r, and the
start year, t0, for urban prevalence in Uganda.
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Fig. 6. Posterior urban prevalence in Uganda, based on increasing observation periods.
Fig. 7. Histograms of samples from the posterior predictive distributions of urban HIV
prevalence in Uganda in 2010, based on increasing observation periods.
rior predictive median was unchanged at 1%; see Figure 6(b). Again, the
subsequent observations lay within the posterior bounds for future overall
prevalence. Using data through 2002, the 95% prediction interval for 2010
is [2%, 7%], with median predicted prevalence of 4%; see Figure 6(c).
The 2010 posterior predictive distributions based on data through 1994,
1998 and 2002 are shown in Figure 7. As more data became available after
1998, prevalence was no longer predicted to decrease to zero.
We have used a prior on outputs that specifies prevalence in 1980 to be
less than 10%. The result of the Bayesian melding procedure without this
prior, using data up to 1994, is shown in Figure 8(b). This figure shows some
prevalence curves in the posterior sample with high prevalence in the early
1980s. This contradicts expert knowledge about the HIV/AIDS epidemic,
and illustrates the need for the direct prior distribution on outputs. This
does not make much of a difference to the predictive distributions of future
prevalence in individual years; for example, the prediction interval for 2010
is [0%, 24%] without the prior information on prevalence in 1980, compared
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to [0%, 23%] with the prior information; the predictive median is 1% for
both. The main difference is that without the prior on outputs, the posterior
includes unrealistic trajectories. Leaving out the prior on outputs does not
change the posterior samples of prevalence curves based on data up to 1998
or 2002.
To assess the fit of our overall modeling procedure, including the EPP
model itself, the Bayesian melding method and the approximations used
in deriving the likelihood, we compared observed clinic prevalence with its
predictive distribution, as described in Section 3.4. Figure 9 shows the pre-
dictive intervals for the two missionary hospitals in Kampala, Nsambya and
Rubaga. Figures 9(a) and 9(d) display prediction intervals based on data
through 1994, and Figures 9(b) and 9(e) display the results using data
through 1998. For both hospitals at both time points, the observed future
prevalences lay within their prediction intervals. These results are consistent
with the statement that EPP model combined with the Bayesian melding
procedure produces reasonable predictive intervals. Two trajectories of sim-
ulated clinic prevalence based on data through 1994 and 1998 are given in
the same figures in grey, as well as in Figure 9(c) and 9(f) for data through
2002, showing that the modeling assumptions made in Section 3.3 represent
the clinic prevalence data reasonably well.
5. Discussion. In this article we have proposed using Bayesian melding
to obtain probabilistic projections of HIV prevalence from the EPP model
developed by UNAIDS. EPP generates HIV prevalence trends for generalized
(a) (b)
Fig. 8. Posterior urban prevalence in Uganda, based on data up to 1994, (a) with a
U(0, 10%) prior distribution on prevalence in 1980, (b) without prior information on
prevalence.
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Fig. 9. Predictive distributions and confidence intervals for the two urban clinics Nsam-
bya and Rubaga in Uganda based on data through 1994, 1998 and 2002. The dotted lines
are the 2.5% and 97.5% quantiles and the solid black line is the median of the predictive
distribution for each year. The black line with the dots shows observed prevalence, and the
grey lines show simulated observed clinic prevalence.
epidemics and is typically fit to trends in the prevalence among women who
attend antenatal clinics. For many countries in sub-Saharan Africa this is the
only available information, a fact that precludes the use of more complicated
models that require detailed information about the behavioral and biological
determinants of an HIV epidemic.
Using the Bayesian melding procedure, uncertainty about future preva-
lence is described by building probabilistic projections. A random effects
model is used to account for differences between clinics, and out-of-sample
predictive distributions are derived and compared with data to assess the
predictive quality of the overall modeling procedure, including the EPP
model, Bayesian melding and the approximations involved in the likelihood.
We applied our method to Uganda where a relatively long series of antena-
tal clinic prevalence observations is available. The out-of-sample predictive
performance of our method was good in this example, which lends support
to the use of Bayesian melding for assessing uncertainty. This also shows
that the relatively simple EPP model itself is effective at predicting preva-
lence, which is reassuring given how widely EPP is used. Further, it indicates
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that the approximations we used in deriving the likelihood have not unduly
affected the procedure’s predictive performance. These include our use of a
normal distribution on the probit scale to approximate the binomial distri-
bution. It would be possible to build a model that instead uses the binomial
response explicitly, but this would be considerably more complicated, and
our results suggest that the gain in performance from doing so would be
modest at best.
We based our prevalence predictions on data from antenatal clinics, which
is the usual way in which the EPP model is used. However, it has been
convincingly argued that prevalence estimates from antenatal clinic data
tend to be biased upward. There are several reasons for this. Young women,
making up a substantial fraction of all pregnant women, tend to have higher
HIV prevalence than the general population [Zaba et al. (2000)]. Also, urban
antenatal clinics tend to be public rather than private and, as a result,
oversample poorer women who are more likely to be HIV positive. Further,
rural antenatal clinics often underrepresent remote rural areas that tend to
have lower prevalence and where a large fraction of the population typically
lives [Saphonn et al. (2002), Boerma et al. (2003)].
Nationally representative population surveys have been proposed as an al-
ternative to antenatal clinic data, particularly the Demographic and Health
Surveys (DHS) [Boerma et al. (2003)]. For countries with national HIV
prevalence estimates, a bias term was included in the 2005 version of EPP
to calibrate the estimates that it produces. There are problems with this
also. The DHS estimates themselves tend to be biased downward largely
due to nonresponse. People not living in households, who are often more
likely to be HIV positive, including sex workers living in brothels, are un-
derrepresented because the DHS is a household survey [Lydie et al. (2004),
Zaba et al. (2004), Mishra et al. (2006)]. The DHS estimates can also be
highly variable, particularly in low prevalence countries where they may be
based on a relatively small number of HIV positive cases.
Future work will extend Bayesian melding for EPP to take account of the
DHS prevalence estimates and information describing possible bias in both
antenatal clinic and DHS data. One possible way of doing this would be to
include a second likelihood based on DHS data, as well as bias terms for
both antenatal clinic and DHS data. Priors for the bias terms could be set
using data from other countries.
More generally, we have used data from a range of countries to set the
priors used. We have done this rather informally, but have got good results
in terms of out-of-sample prediction. A more formal and comprehensive way
of doing this would be to build a Bayesian hierarchical model for the data
on a set of comparable countries, with country being an additional level of
the hierarchy. We did not use such a model here because it is important
that officials from each country be able to develop and modify their own
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estimates and projections of HIV/AIDS. Thus, UNAIDS provides tools for
them to do this, along with suggested defaults, including suggested priors.
In practice, this means that a one-country approach must be used. A more
comprehensive multi-country Bayesian hierarchical model would be a rea-
sonable project for future work and could help set the priors for individual
countries in a more formal and reproducible way. However, our results are
relatively insensitive to changes in the priors we have used, and so it seems
unlikely that a more comprehensive approach would give very different re-
sults from the one-country method we have developed here. The obstacles
to a more comprehensive multi-country modeling approach may be more
political than statistical.
When constructing HIV projections in the future, the availability and pos-
sible effects of antiretroviral therapy (ART) will also need to be taken into
account. So far the availability of ART is limited and the effects negligible.
Recently, Botswana and South Africa were two of the first countries in sub-
Saharan Africa to establish national ART programs. Other possible model
improvements for EPP include additional parameters to model behavioral
change, such as time variation in the force of infection to deal with rapid
changes in behavior occurring in some countries [Ghys et al. (2006)]. How-
ever, it is not clear that making the model more complicated will improve
its performance; whether or not this is the case in the presence of limited
data is an empirical question.
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